Molecular epidemiology of viral diseases in the era of next generation sequencing

Journal of Clinical Virology

Volumn 57, Issue 4, 2013, Pages 378-380

  Cruz Rivera, Mayra ^a   Forbi, Joseph C ^b,e   Yamasaki, Lilian H T ^c   Vazquez Chacon, Carlos A ^b   Martinez Guarneros, Armando ^b   Carpio Pedroza, Juan C ^b   Escobar Gutiérrez, Alejandro ^b   Ruiz Tovar, Karina ^b   Fonseca Coronado, Salvador ^d   Vaughan, Gilberto ^b,e  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b Instituto Nacional de Diagnostico y Referencia Epidemiologicos   (Mexico)

^c SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^d UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

UNTRANSLATED RNA;

BINDING SITE; DNA SEQUENCE; EPIGENETICS; GENE MUTATION; GENE SEQUENCE; GENETIC RISK; GENETIC VARIABILITY; HEALTH CARE POLICY; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; METAGENOMICS; MOLECULAR DYNAMICS; MOLECULAR EPIDEMIOLOGY; NEXT GENERATION SEQUENCING; NONHUMAN; NOTE; PHENOTYPE; PRIORITY JOURNAL; VACCINATION; VIRUS INFECTION; VIRUS REPLICATION; VIRUS TRANSMISSION;

ANIMALS; GENETIC VARIATION; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MOLECULAR EPIDEMIOLOGY; SEQUENCE ANALYSIS, DNA; VIRUS DISEASES;

EID: 84879259420     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.04.021     Document Type: Note

References (33)

1. Breuer J. VZV molecular epidemiology. Curr Top Microbiol Immunol 2010, 342:15-42.
2. Domingo E., Sheldon J., Perales C. Viral quasispecies evolution. Microbiol Mol Biol Rev 2012, 76:159-216.
3. Ramachandran S., Xia G.L., Ganova-Raeva L.M., Nainan O.V., Khudyakov Y. End-point limiting-dilution real-time PCR assay for evaluation of hepatitis C virus quasispecies in serum: performance under optimal and suboptimal conditions. J Virol Methods 2008, 151:217-224.
4. Ganova-Raeva L.M., Dimitrova Z.E., Campo D.S., Lin Y., Ramachandran S., Xia G.L., et al. Detection of hepatitis C virus transmission by use of DNA mass spectrometry. J Infect Dis 2013, 207:999-1006.
5. Ramachandran S., Campo D.S., Dimitrova Z.E., Xia G.L., Purdy M.A., Khudyakov Y.E. Temporal variations in the hepatitis C virus intrahost population during chronic infection. J Virol 2011, 85:6369-6380.
6. Fonseca-Coronado S., Escobar-Gutierrez A., Ruiz-Tovar K., Cruz-Rivera M.Y., Rivera-Osorio P., Vazquez-Pichardo M., et al. Specific detection of naturally occurring hepatitis C virus mutants with resistance to telaprevir and boceprevir (protease inhibitors) among treatment-naive infected individuals. J Clin Microbiol 2012, 50:281-287.
7. Capobianchi M.R., Giombini E., Rozera G. Next-generation sequencing technology in clinical virology. Clin Microbiol Infect 2013, 19:15-22.
8. Alhamlan F.S., Ederer M.M., Brown C.J., Coats E.R., Crawford R.L. Metagenomics-based analysis of viral communities in dairy lagoon wastewater. J Microbiol Methods 2012, 92:183-188.
9. Van Borm S., Rosseel T., Steensels M., van den Berg T., Lambrecht B. What's in a strain? Viral metagenomics identifies genetic variation and contaminating circoviruses in laboratory isolates of pigeon paramyxovirus type 1. Virus Res 2013, 171(1):186-193.
10. Wong K., Fong T.T., Bibby K., Molina M. Application of enteric viruses for fecal pollution source tracking in environmental waters. Environ Int 2012, 45:151-164.
11. Bibby K., Viau E., Peccia J. Viral metagenome analysis to guide human pathogen monitoring in environmental samples. Lett Appl Microbiol 2011, 52:386-392.
12. Palacios G., Druce J., Du L., Tran T., Birch C., Briese T., et al. A new arenavirus in a cluster of fatal transplant-associated diseases. N Engl J Med 2008, 358:991-998.
13. Chin-Inmanu K., Suttitheptumrong A., Sangsrakru D., Tangphatsornruang S., Tragoonrung S., Malasit P., et al. Feasibility of using 454 pyrosequencing for studying quasispecies of the whole dengue viral genome. BMC Genomics 2012, 13(Suppl. 7):S7.
14. Lauck M., Alvarado-Mora M.V., Becker E.A., Bhattacharya D., Striker R., Hughes A.L., et al. Analysis of hepatitis C virus intrahost diversity across the coding region by ultradeep pyrosequencing. J Virol 2012, 86:3952-3960.
15. Zell R., Taudien S., Pfaff F., Wutzler P., Platzer M., Sauerbrei A. Sequencing of 21 varicella-zoster virus genomes reveals two novel genotypes and evidence of recombination. J Virol 2012, 86:1608-1622.
16. Mancuso N., Tork B., Skums P., Ganova-Raeva L., Mandoiu I., Zelikovsky A. Reconstructing viral quasispecies from NGS amplicon reads. In Silico Biol 2012, 11:237-249.
17. Astrovskaya I., Tork B., Mangul S., Westbrooks K., Mandoiu I., Balfe P., et al. Inferring viral quasispecies spectra from 454 pyrosequencing reads. BMC Bioinform 2011, 12(Suppl. 6):S1.
18. Bull R.A., Luciani F., McElroy K., Gaudieri S., Pham S.T., Chopra A., et al. Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection. PLoS Pathogens 2011, 7:e1002243.
19. Cruz-Rivera M., Carpio-Pedroza J.C., Escobar-Gutierrez A., Lozano D., Vergara-Castaneda A., Rivera-Osorio P., et al. Rapid hepatitis C virus divergence among chronically infected individuals. J Clin Microbiol 2013, 51(2):629-632.
20. Escobar-Gutierrez A., Vazquez-Pichardo M., Cruz-Rivera M., Rivera-Osorio P., Carpio-Pedroza J.C., Ruiz-Pacheco J.A., et al. Identification of hepatitis C virus transmission using a next-generation sequencing approach. J Clin Microbiol 2012, 50:1461-1463.
21. Forbi J.C., Purdy M.A., Campo D.S., Vaughan G., Dimitrova Z.E., Ganova-Raeva L.M., et al. Epidemic history of hepatitis C virus infection in two remote communities in Nigeria. West Afr J Gen Virol 2012, 93:1410-1421.
22. Rodriguez-Frias F., Tabernero D., Quer J., Esteban J.I., Ortega I., Domingo E., et al. Ultra-deep pyrosequencing detects conserved genomic sites and quantifies linkage of drug-resistant amino acid changes in the hepatitis B virus genome. PLoS ONE 2012, 7:e37874.
23. Nowak P., Karlsson A.C., Naver L., Bohlin A.B., Piasek A., Sonnerborg A. The selection and evolution of viral quasispecies in HIV-1 infected children. HIV Med 2002, 3:1-11.
24. Poon A.F.Y., McGovern R.A., Mo T., Knapp D.J.H.F., Brenner B., Routy J.P., et al. Dates of HIV infection can be estimated for seroprevalent patients by coalescent analysis of serial next-generation sequencing data. AIDS 2011, 25:2019-2026.
25. Wang C., Mitsuya Y., Gharizadeh B., Ronaghi M., Shafer R.W. Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance. Genome Res 2007, 17:1195-1201.
26. Simen B.B., Simons J.F., Hullsiek K.H., Novak R.M., MacArthur R.D., Baxter J.D., et al. Low-Abundance Drug-Resistant Viral Variants in Chronically HIV-Infected, Antiretroviral Treatment-Naive Patients Significantly Impact Treatment Outcomes. J Infect Dis 2009, 199:693-701.
27. Schirmer M., Sloan W.T., Quince C. Benchmarking of viral haplotype reconstruction programmes: an overview of the capacities and limitations of currently available programmes. Brief Bioinform 2012.
28. Quince C., Lanzen A., Curtis T.P., Davenport R.J., Hall N., Head I.M., et al. Accurate determination of microbial diversity from 454 pyrosequencing data. Nat Methods 2009, 6:639-641.
29. Barzon L., Lavezzo E., Militello V., Toppo S., Palu G. Applications of next-generation sequencing technologies to diagnostic virology. Int J Mol Sci 2011, 12:7861-7884.
30. Zagordi O., Bhattacharya A., Eriksson N., Beerenwinkel N. ShoRAH: estimating the genetic diversity of a mixed sample from next-generation sequencing data. BMC Bioinform 2011, 12:119.
31. Zagordi O., Daumer M., Beisel C., Beerenwinkel N. Read length versus depth of coverage for viral quasispecies reconstruction. PLoS ONE 2012, 7:e47046.
32. Skums P., Dimitrova Z., Campo D.S., Vaughan G., Rossi L., Forbi J.C., et al. Efficient error correction for next-generation sequencing of viral amplicons. BMC Bioinform 2012, 13(Suppl. 10):S6.
33. Skums P., Campo D.S., Dimitrova Z., Vaughan G., Lau D.T., Khudyakov Y. Numerical detection, measuring and analysis of differential interferon resistance for individual HCV intra-host variants and its influence on the therapy response. In Silico Biol 2012, 11:263-269.